![CEM BUSINESS – jedinečný nástroj pro komplexní správu lokálních distribučních soustav - Časopis Elektro - Odborné časopisy CEM BUSINESS – jedinečný nástroj pro komplexní správu lokálních distribučních soustav - Časopis Elektro - Odborné časopisy](http://www.odbornecasopisy.cz/img/content/0506_1.png)
CEM BUSINESS – jedinečný nástroj pro komplexní správu lokálních distribučních soustav - Časopis Elektro - Odborné časopisy
Test–retest reliability of selected HBSC items in Vietnam: well-being, physical and sedentary activities, and eating behaviour
![A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles - ScienceDirect A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0001868621001366-gr1.jpg)
A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles - ScienceDirect
![PDF) Influence of thermal history on the photostructural changes in glassy As15S85 studied by Raman scattering and ab initio calculations PDF) Influence of thermal history on the photostructural changes in glassy As15S85 studied by Raman scattering and ab initio calculations](https://i1.rgstatic.net/publication/260707922_Influence_of_thermal_history_on_the_photostructural_changes_in_glassy_As15S85_studied_by_Raman_scattering_and_ab_initio_calculations/links/0f317532465f39cddf000000/largepreview.png)
PDF) Influence of thermal history on the photostructural changes in glassy As15S85 studied by Raman scattering and ab initio calculations
Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
![Cancers | Free Full-Text | Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use | HTML Cancers | Free Full-Text | Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use | HTML](https://www.mdpi.com/cancers/cancers-14-02640/article_deploy/html/images/cancers-14-02640-g001-550.jpg)
Cancers | Free Full-Text | Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use | HTML
![Cancers | Free Full-Text | Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL | HTML Cancers | Free Full-Text | Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL | HTML](https://www.mdpi.com/cancers/cancers-13-01280/article_deploy/html/images/cancers-13-01280-g001-550.jpg)